Why is Life Science Real Estate Unique?

1

Clustering: The clustering of medical device and biotech site locations in few select US cities for access to talent, investors, consultants, and other resources.

2

Quality Compliance: Building and facilities are subject to quality compliance such as ISO 13485, ISO 14644 cleanroom standards, and FDA 21 CFR 211 outlining Current Good Manufacturing Practices (cGMP).

3

Flexibility: Necessary flexibility in manufacturing and office layouts, and flexibility in lease term/options for maximum efficiencies.

Where Life Science and Real Estate Unite

For the Life Science Industry, the right space is the lifeblood of your success. When leasing, buying or selling using a commercial real estate broker with first-hand medical device and biotech experience can be the difference between success and failure.
Here’s why:

1. Life Science industry intelligence of changing trends
  • Consolidation of life sciences companies through M&A activity
  • EU MDR changes impacting regulatory/quality
  • Heavy outsourcing of major functions through use of consultants, design, contract manufacturers, packaging, sterilization, and other life science focused support firms commercialization, saving time and money. Brookshire assists you in making wise real estate decisions by weighing options against broader industry trends. Avoid mistakes, increases efficiency, and achieve faster commercialization, saving time and money.
2. Former Medical Device Consultant

Having consulted to hundreds of life science start-ups and mid-size organizations, Brookshire can assist in protecting core business goals, funding sources, milestones, outsourcing, and exit strategies when making real estate and location decisions. Align and integrate your building and facility footprint with your business model. Establish strategic location(s) and scalable, flexible spaces to enable future growth. Save time and money by offloading search and negotiation processes.

3. Maintain compliance to ISO 14644, ISO 13485, and FDA CFR 820, 211

With a 10 year medical device background with heavy emphasis on Regulatory and Quality, we understand that compliance to ISO 14644, ISO 13485, and Current Good Manufacturing Practices (cGMP) as it relates to cleanrooms, quality systems, and facilities can be difficult. Help alleviate the burden on operations and quality staff in evaluating existing and expanding space requirements. Ensure building is capable of supporting core functions and maintaining compliance for continued success. Help avoid ISO noncompliance, FDA Form 483, or FDA Warning Letter due to facility issues.

4. Cleanroom Manufacturing

Having a commercial real estate broker with an understanding of necessary facility requirements for cleanrooms gives you the ability to locate building options that either meet or exceed requirements necessary to support cleanrooms such as:

  • First floor location
  • Required clear height
  • HVAC capacity
  • Electrical and other mechanical requirements
  • Roof support
  • NEBB Procedural Standards
  • Other considerations for common ISO Classes (5-8) for Life Science companies
  • ISO 14644 international cleanroom standards

Save time and money by finding the right property the first time and eliminating the need for heavy capital investment to retrofit for cleanroom purposes.

Real Estate with real-world experience
  • ISO Class 5-8 Cleanroom construction and certification
  • SO 14644-1: Classification of air cleanliness in cleanrooms
  • Wet and Dry lab
  • Temperature and humidity controls
  • FDA CFR 211: cGMP
  • FDA CFR 820: QMS
  • ISO 13485: 2016 Medical Device Quality Management System
  • Active member of Medical Alley Association (MN)

Teleflex Medical: Lease renewals, facility expansions and project management

  • Specialize in medical technologies that provide solutions in fields of vascular and interventional access, surgical and many more areas of healthcare.
  • Teleflex has 12,000 employees and generates $2.4 Billion in annual revenue

Boston Scientific/Guidant: Multiple dispositions via sublease & sale of surplus facilities located domestic and international

  • Specialize in artificial cardiac pacemakers, cardioverter/defibrillators, and other cardiovascular products.
  • Boston Scientific has 36,000 employees and generates $10 Billion in annual revenue

Teva Pharma/Cephalon/Cima: Disposition of 125k sq. ft. facility to user requiring cleanroom manufacturing

  • Specialize in manufacturing drugs to help with sleeping disorders, cancer, and other illnesses.
  • Teva Pharmaceuticals has 40,000 employees and generates $17 Billion in annual revenue

Michael leads The Brookshire Company’s active involvement in MN’s Medical Alley Association, and represents Life Science users with acquisitions, dispositions, site selection, tenant rep leasing, and cleanroom manufacturing and distribution consulting. Learn More

Let's have a conversation on how we can help you.

Contact Us